| ID | Name | CAS | Data |
MW (g/mol) |
| 14-578-5 |
Phosphorothioic acid, s-ester with n-[4-[(3-hydroxypropyl)amino]butyl]phthalimide
|
|
2 | 372.38 |
| 14-670-2 |
17-«beta»-Methyl-5-«beta»-androstan-3-«beta»,17-«alpha»-diol, per-TMS
|
|
2 | 450.85 |
| 14-672-0 |
Silane, dimethyl(dimethyl(2,6-dimethylnon-1-en-3-yn-5-yloxy)silyloxy)ethoxy-
|
|
2 | 342.63 |
| 14-794-5 |
tert-Butyl(dimethyl)silyl 4-(2-aminophenyl)-2-pyrrol[tert-butyl(dimethyl)silyl]aminomorpho-4-oxobutanoate
|
|
2 | 436.74 |
| 14-831-3 |
6-Bromo-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-L-threo-hexono-1,4-lactone
|
|
2 | 323.30 |
| 14-959-2 |
3«alpha»,7«beta»,17«alpha»-trihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
2 | 753.40 |
| 15-049-1 |
5-«alpha»-Pregnan-3-«beta»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 553.05 |
| 15-054-5 |
[1,2,4]Triazolo[1,5-a]pyrimidin-7-ol, 5-methyl-
|
2503-56-2 |
2 | 150.14 |
| 15-062-6 |
5«alpha»-Androstan-3«alpha»,11«beta»-diol-17-one, TMS
|
|
2 | 522.98 |
| 15-132-8 |
13,14-Dihydro-15-keto-PGF1A, BO-TMS, isomer # 2
|
|
2 | 644.18 |
| 15-223-7 |
Benzenepropanoic acid, «alpha»,4-bis[(tert-butyldimethylsilyl)oxy]-, tert-butyldimethylsilyl ester
|
|
2 | 524.97 |
| 15-229-1 |
D-2-Aminobutyric acid, N-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 331.64 |
| 15-303-8 |
1,3-Disiloxane, 1,3-diethoxy, 1,3-ethyl, 1,3-bis-(chloromethyl)
|
|
2 | 319.37 |
| 15-348-9 |
«alpha»-Ketoglutaric acid, tert-butyldimethylsilyl ether, bis(tert-butyldimethylsilyl) ester
|
|
2 | 488.88 |
| 15-371-3 |
Pregnan-17-ol, 3,20-bis[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»,20S)-
|
17562-94-6 |
2 | 480.87 |
| 15-402-8 |
17-«beta»-Methyl-5-«alpha»-androstan-3-«alpha»,17-«alpha»-diol, per-TMS
|
|
2 | 450.85 |
| 15-426-2 |
tert-Butyldimethylsilyl 2-[(tert-butyldimethylsilyl)amino]-3-(4-[(tert-butyldimethylsilyl)oxy]-3-chlorophenyl)propanoate
|
|
2 | 558.43 |
| 15-482-0 |
Methyl 3-«beta»,7-«alpha»,12-«alpha»-trihydroxy-5-«beta»cholanoate, TMS
|
|
2 | 639.14 |
| 15-653-0 |
9-Dodecyn-1-ol, dimethyl(dimethyl(dimethyl(pyrid-2-ylmethoxy)silyloxy)silyloxy)silyl ether
|
|
2 | 495.88 |
| 15-658-5 |
5-Pregnane-11-one-3«alpha»,20«alpha»-diol, MO-TMS
|
|
2 | 507.90 |
| 15-726-9 |
3-Deoxy-2-C-hydroxymethyl-threo-pentonic acid, pentakis-TMS
|
|
2 | 541.06 |
| 15-894-3 |
3,5-Dideoxy-threo-pentonic acid, 1,4-lactone, TMS
|
|
2 | 188.30 |
| 16-044-5 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1 -benzo[1,3]dioxol-5-yl-propan-1-ol, TES
|
|
2 | 502.67 |
| 16-265-0 |
13,14-Dihydro-15-keto-PGE2, BO-TMS, isomer # 3
|
|
2 | 639.07 |
| 16-315-4 |
6-Azido-5-tert-butyldimethylsilyloxy-2,3,6-trideoxy-D-erythro-hexono-1,4-lactone
|
|
2 | 285.41 |
| 16-354-1 |
1H-pyrazolo[3,4-d]pyrimidine, 4-amino-1-methyl-
|
|
2 | 149.16 |
| 16-373-0 |
5«beta»-Pregnan-3«alpha»,11«beta»,17«alpha»,21-tetrol-20-one, MO-TMS (11-OH)
|
|
2 | 598.05 |
| 16-398-3 |
1H-pyrido[3,4-b]indole-3-carboxylic acid, 2,3,4,9-tetrahydro-
|
|
2 | 216.24 |
| 16-514-3 |
Vobassan-17-oic acid, 4-demethyl-3-oxo-, methyl ester
|
2673-40-7 |
2 | 338.40 |
| 16-658-4 |
2-Pentenoic acid, 3-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
55320-09-7 |
2 | 274.50 |
| 16-777-2 |
5«alpha»-Androst-1-ene-3«alpha»,17«alpha»-diol, per-TMS
|
|
2 | 434.80 |
| 16-784-4 |
2-Bromo-2-nitro-propane-1,3-diol, bis(trimethylsilyl)- ether
|
|
2 | 344.35 |
| 16-881-6 |
Oxadiazole, 1,3,4-, 2-methylthio-5-(5-nitro-2-furyl)-
|
98273-49-5 |
2 | 227.20 |
| 16-893-3 |
Glycine, N-[«alpha»-[(tert-butyldimethylsilyl)oxy]benzylidene]-, tert-butyldimethylsilyl ester
|
|
2 | 407.69 |
| 16-999-6 |
[(3S,4r,5s)-4-acetyloxy-5-(acetyloxymethyl)-2-(2,6-diaminopurin-9-yl)oxolan-3-yl] acetate
|
|
2 | 408.37 |
| 17-041-7 |
Adenosine, 2'-deoxy-N-(trimethylsilyl)-3'-O-(trimethylsilyl)-, 5'-[bis(trimethylsilyl) phosphate]
|
32645-70-8 |
2 | 619.95 |
| 17-058-9 |
(3R,4S)-3-tert-Butyldimethylsilyloxy-1-tert-butoxycarbonyl-4-hydroxyazepane
|
|
2 | 345.55 |
| 17-101-0 |
17-«alpha»-Methyl-5-«beta»-androstan-3-«beta»,17-«beta»-diol, per-TMS
|
|
2 | 450.85 |
| 17-256-9 |
5-«alpha»-Pregnan-3-«beta»,11-«beta»,20-«alpha»-triol, TMS
|
|
2 | 553.05 |
| 17-284-8 |
D-(+)-Glucuronic acid «gamma»-lactone, tris(trimethylsilyl) ether (isomer 1)
|
|
2 | 392.67 |
| 17-327-0 |
8,8'-Methylene bis-(6-chloro-3,4-dihydro-3-phenyl-2h, 1,3-benzoxazine)
|
|
2 | 503.43 |
| 17-328-9 |
Pentanedioic acid, 3-methyl-3-[(trimethylsilyl)oxy]-, bis(trimethylsilyl) ester
|
55590-95-9 |
2 | 378.68 |
| 17-381-0 |
5«beta»-Pregnan-3«alpha»,17«alpha»,21-triol-11,20-dione, MO-TMS
|
|
2 | 625.08 |
| 17-408-0 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-4.«alpha»,17«beta»-diol, bisTMIPS
|
|
2 | 557.01 |
| 17-494-5 |
3,4-Diacetyl-5-oxo-1,3,4-thiadiazolidone-2-azine
|
108952-44-9 |
2 | 400.39 |
| 17-533-1 |
5-«beta»-Pregnan-20-«beta»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 17-534-0 |
2-(2,6-Bis(tert-butyldimethylsilyl)-3,4-2H-3-pyridyl)isoindoline-1,3-dione
|
|
2 | 486.76 |
| 17-540-3 |
5«alpha»-Androst-1-ene-3«alpha»,17«beta»-diol, per-TMS
|
|
2 | 434.80 |
| 17-645-7 |
5«beta»-Androst-1-ene-3«beta»,17«alpha»-diol, per-TMS
|
|
2 | 434.80 |
| 17-683-5 |
N-Trifluoroacetyl-O,O'-bis(trimethylsilyl)-l-dopa, trimethylsilyl ester
|
|
2 | 509.74 |
| 17-820-2 |
Benzenepropanol, 3-methoxy-4-(1-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl))ethyl, tris-TMS
|
|
2 | 562.97 |
| 17-884-2 |
13,14-Dihydro-15-keto-TxB2, BO-TMS, isomer # 2
|
|
2 | 658.14 |
| 17-953-5 |
Benzenepropanol, 3-hydroxy-4-(1-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl))ethyl, tetrakis-TMS
|
|
2 | 621.12 |
| 17-996-8 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, bis-TMS
|
|
2 | 370.64 |
| 18-051-5 |
Galactaric acid, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
56272-61-8 |
2 | 643.23 |
| 18-208-1 |
3-oxo-4,6-chol-24-oate, O-methyloxime (1)
|
|
2 | 471.75 |
| 18-247-8 |
3«alpha»,7«alpha»,12«alpha»,26-tetrahydroxy-5«beta»-cholestanoate, methyl ester-trimethylsilyl ether
|
|
2 | 769.40 |
| 18-257-7 |
d-Mannose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
128705-61-3 |
2 | 570.10 |
| 18-442-1 |
3,16-Bis[(trimethylsilyl)oxy]androstane, (3«beta»,5«alpha»,16«beta»)-
|
37977-24-5 |
2 | 436.82 |
| 18-455-7 |
1,2-Benzisothiazolin-3-one, 2-(0-tolylsulfonyl)-, 1,1-dioxide
|
116400-87-4 |
2 | 337.37 |
| 18-468-3 |
5-Pregnen-3-«beta»,11-«beta»,20-«beta»-triol, TMS
|
|
2 | 551.04 |
| 18-477-3 |
1H-3-benzazepine, 4-acetamido-3-acetyl-2,3-dihydro-
|
|
2 | 244.29 |
| 18-650-0 |
Methyltestosterone M (5B-Androstan-17A-methyl-3A,17B-diol), TMS
|
|
2 | 450.85 |
| 18-742-8 |
(Z)-Trimethylsilyl 7-((2R,3R,4S)-4,6-bis(trimethylsilyloxy)-2-[(S,E)-3-(trimethylsilyloxy)oct-1-enyl]-tetrahydro-2H-pyran-3-yl)hept-5-enoate
|
|
2 | 659.20 |
| 18-772-5 |
Benzenamine, N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]-2-thiazolidinylidene]-
|
37893-02-0 |
2 | 416.34 |
| 18-794-1 |
Benzenepropanol, 3-hydroxy-4-(2-hydroxy-1-hydroxymethyl-2-(4-hydroxy-3-methoxyphenyl))ethyl, pentakis-TMS
|
|
2 | 709.30 |
| 19-147-8 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3-methoxy, butylboronate
|
|
2 | 322.21 |
| 19-220-6 |
3-«beta»,7-«alpha»-Dihydroxy-5-androsten-17-one, MO TMS
|
|
2 | 477.83 |
| 19-224-2 |
2,2,4,4,6,6,8,8,10,10,12-undecamethyl-12-(2-cyanoethyl)-[1,3,5,7,9,11,2,4,6,8,10,12]cyclohexasiloxane
|
|
2 | 483.97 |
| 19-230-5 |
3,4-Diacetyl-5-thione-1,3,4-thiadiazolidone-2-azine
|
108040-17-1 |
2 | 432.52 |
| 19-237-8 |
5-«beta»-Pregnan-3-«beta»-ol-11,20-dione, MO-TMS
|
|
2 | 462.74 |
| 19-282-8 |
2,4,6-TRI(1-AZIRIDINYL)-1,3,5-TRIAZINE
|
|
2 | 204.24 |
| 19-306-1 |
5-«beta»-Pregnan-20-«alpha»-ol-11-one, MO-TMS
|
|
2 | 419.72 |
| 19-366-5 |
Silane, diphenyl(2,2,3,4,4,4-hexafluorobutoxy)undecyloxy-
|
|
2 | 534.66 |
| 19-415-0 |
Benzofuran-2,3-dione, 2-[O-(2-hydroxyethyl)oxime], 3-(O-methyloxime), TMS, isomer 1
|
|
2 | 308.41 |
| 19-497-0 |
4-Hydroxy-4-phenyl-3,5,5-trimethylthiazolidine-2-thione
|
95982-07-3 |
2 | 253.38 |
| 19-522-1 |
4-(1-Trimethylsilyloxy-1-methyl-ethyl)-1-methyl-cyclohexan-1-ol, trimethylsilyl ether
|
|
2 | 316.63 |
| 19-548-3 |
Methyl 5-«beta»-cholan-7-«alpha»-12-«alpha»-diol-3-one-24-oate, oxime, TMS
|
|
2 | 652.14 |
| 19-595-1 |
(1R,4S,5S)-4-tert-Butyldimethylsilyloxy-2-aza-8-oxabicyclo[3,2,1]octane
|
|
2 | 243.42 |
| 19-642-8 |
Arabino-Hexonic acid, 3-deoxy-2,4,5,6-tetrakis-O-(trimethylsilyl)-, trimethylsilyl ester
|
55517-66-3 |
2 | 541.06 |
| 19-672-5 |
Arabino-hexaric acid, 3-deoxy-2,4,5-tris-O-(trimethylsilyl)-, bis(trimethylsilyl) ester
|
38165-99-0 |
2 | 555.04 |
| 19-685-1 |
cis-Phenanthrene, 9,10-dihydro-9-methyl-9,10-diol, 3-methoxy, bis-TMS
|
|
2 | 400.66 |
| 19-728-3 |
Silane, diphenylundecyloxy(1,1,1-trifluoro-3-bromoprop-2-yloxy)-
|
|
2 | 545.55 |
| 19-741-8 |
5«alpha»-Androstan-17«alpha»-methyl-3«alpha»,17«beta»-diol, TMS
|
|
2 | 450.85 |
| 19-788-7 |
d-Galactose, 2,3,4,5,6-pentakis-O-(trimethylsilyl)-, o-methyloxyme, (1E)-
|
128705-64-6 |
2 | 570.10 |
| 19-830-9 |
d-Ribose, 2,3,4,5-tetrakis-O-(trimethylsilyl)-, O-methyloxime
|
56196-08-8 |
2 | 467.90 |
| 19-909-2 |
5-«alpha»-Pregnan-11-«beta»-ol-3,20-dione, MO-TMS
|
|
2 | 462.74 |
| 19-927-2 |
4-Chloro-17A-methyl-1,4-abdrosten-3-one-6B,17B-diol, di-TMS
|
|
2 | 495.24 |
| 19-953-3 |
3-«alpha»,7-«alpha»-Dihydroxy-12-keto-5-«beta»-cholanoic acid, MeTMS
|
|
2 | 564.94 |
| 19-970-4 |
4-(tert-Butyldimethylsilyl)oxy-3-methylbenzoic acid, tert-butyldimethylsilyl ester
|
|
2 | 380.68 |
| 19-996-6 |
5-(3'-Methyl-3'-cyclohexyl-1'-triazeno)imidazole-4-carboxylic acid, ethyl ester
|
36137-87-8 |
2 | 279.34 |
| 20-052-1 |
p-Tolyl-«beta»-D-glucuronide, tris(trimethylsilyl) ether, trimethylsilyl ester
|
|
2 | 572.99 |
| 20-126-9 |
16«alpha»,17-diOH-fujanoic acid, methyl ester TMS ether
|
|
2 | 554.86 |
| 20-141-2 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«beta»-triol, methylboronate, TMS
|
|
2 | 432.52 |
| 20-167-4 |
4,6-Pteridinediol, 2-(tert.butyl)dimethylsilylamino-, O,O-bis(t(tert.butyl)dimethylsilyl-, ether
|
|
2 | 521.93 |
| 20-169-2 |
5,6-Dichloro-1,3-benzothiazol-2-(N-trimethylsilyl)amine
|
|
2 | 291.27 |
| 20-232-1 |
tert-Butyl-[2-[2-[2-(tert-butyldimethylsilyl)oxyethoxy]ethoxy]ethoxy]dimethylsilane
|
|
2 | 378.69 |
| 20-239-4 |
Imidazole-4-carboxylic acid, 5-(3-methyl-3-octyltriazeno)-, ethyl ester
|
36137-96-9 |
2 | 309.41 |
| 20-295-2 |
3A,17A,21-Trihydroxy-5B-pregnan-11,20-dione, MO TMS
|
|
2 | 639.10 |
| 20-315-9 |
17«alpha»,20«beta»,21-Trihydroxypregn-4-en-3-one, 3-MO, 17,20,21-tris-TMS
|
|
2 | 594.06 |
|
« Previous Results
Next Results »
|